Clinical trial
Biomarkers for Babies and Young Children With Ataxia Telangiectasia (The BOBCAT Study)
NCT07709728 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarkers for Babies and Young Children With Ataxia Telangiectasia (The BOBCAT Study)
- Lead sponsor
- University of Nottingham
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- August 31, 2029
- Enrollment
- 56 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.